{"id": "batch_req_68014b704ea08190bc809f69f06dd275", "custom_id": "alendronic acid-Lamivudine-Metoprolol-Perphenazine-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "58b69b21405bd77e50e8c2c52367c769", "body": {"id": "chatcmpl-BNOSvSzJ5hJyKPCE3BfqZGmnjivAM", "object": "chat.completion", "created": 1744915289, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated with a cardioselective \u03b21-adrenergic receptor antagonist known for its pivotal role in cardiovascular therapeutics develops insulin dependent diabetes mellitus after starting a medication that is a typical antipsychotic, classified as a piperazinyl phenothiazine, and considered roughly ten times as potent as chlorpromazine at the D2 receptor. Which medication was added?\n\nAnswer: Perphenazine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1046, "completion_tokens": 86, "total_tokens": 1132, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b7064748190845bcfe637fb6984", "custom_id": "alendronic acid-Dipyridamole-Sildenafil-Zaleplon-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "95d491144bd2624c67aba30fdeeaf03d", "body": {"id": "chatcmpl-BNOSumEDAj2vqA5HcTCe6tF2DEmVY", "object": "chat.completion", "created": 1744915288, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA medication that functions as a selective phosphodiesterase type 5 inhibitor, known for its rapid onset and vasodilatory effects (and which can cause severe hypotension with nitrates), may lead to the rare adverse event of apoplexy when taken concurrently with a sedative-hypnotic agent from the pyrazolopyrimidine class used in the management of insomnia. Which agent, fitting the latter description, is associated with this interaction?\n\nAnswer: Zaleplon", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 889, "completion_tokens": 100, "total_tokens": 989, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b7075c8819099029628cd326d5b", "custom_id": "Fentanyl-Dexpramipexole-Ticlopidine-Tirofiban-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "47b6d997df4fe2441e681260e2f81fd3", "body": {"id": "chatcmpl-BNOSugFAdGr2XFfd1I9mQhWuyPQUy", "object": "chat.completion", "created": 1744915288, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated with an older antiplatelet thienopyridine, originally used when aspirin was contraindicated, develops thrombocytopenia after starting a medication that is a small molecule antagonist of the fibrinogen-platelet integrin GP IIb/IIIa interaction and is the first of its class to originate from pharmacophore-based virtual screening. Which drug is most likely responsible for this thrombocytopenia?\n\nAnswer: Tirofiban", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1001, "completion_tokens": 96, "total_tokens": 1097, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b7085448190a40fdacae43668d5", "custom_id": "Naproxen-Gabapentin-Sildenafil-Zaleplon-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "88a6a8efaadb24782d9b3d4362964e5e", "body": {"id": "chatcmpl-BNOSuHmSMDNWuxAB8Ufj6CkHMZl3x", "object": "chat.completion", "created": 1744915288, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nAmong the following drugs\u2014one commonly used for insomnia as a nonbenzodiazepine sedative-hypnotic, another that enhances nitric oxide-mediated vasodilation, a third that binds to neuronal calcium channel subunits to manage neuropathic pain, and a fourth that inhibits prostaglandin synthesis for anti-inflammatory effects\u2014which drug, when taken with the phosphodiesterase type 5 inhibitor, is associated with an increased risk of apoplexy according to documented drug interactions?\n\nAnswer: Zaleplon", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1143, "completion_tokens": 106, "total_tokens": 1249, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b709840819081df818a7252a2d7", "custom_id": "Gabapentin-Ketorolac-Oxaprozin-Sildenafil-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "380ae02a1c0ab952232a518c799c1752", "body": {"id": "chatcmpl-BNOSwrJeESXxNKJRpJ5t7LkaW6dWB", "object": "chat.completion", "created": 1744915290, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient is managing osteoarthritis with a propionic acid-derived NSAID known for use in both adults and children with juvenile rheumatoid arthritis, and now experiences an adverse gastrointestinal effect characterized by gastric inflammation after adding a potent PDE5 inhibitor that enhances nitric oxide-mediated vasodilation for conditions such as erectile dysfunction and pulmonary arterial hypertension. Based on these drug interaction profiles, which medication, when combined with the propionic acid-derived NSAID, is associated with this specific gastrointestinal risk?\n\nAnswer: Sildenafil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1222, "completion_tokens": 99, "total_tokens": 1321, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b70ade481909cdf50067a602e62", "custom_id": "Citalopram-Fenofibrate-Modafinil-Bimatoprost-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "aa6603d65bd9d0da038a1458327a84da", "body": {"id": "chatcmpl-BNOSxbkYkInoLB9uwBWPLQv2Pyf52", "object": "chat.completion", "created": 1744915291, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA central nervous system stimulant used primarily for sleep disorders, which is associated with anxiety and insomnia as potential adverse effects, can lead to increased nocturia when used in combination with a prostaglandin analog administered as an eye drop for glaucoma and eyelash enhancement. Which medication, known to sometimes cause red eyes, dry eyes, and changes in eye color, is involved in this interaction?\nAnswer: Bimatoprost", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1219, "completion_tokens": 86, "total_tokens": 1305, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b70bdc0819083a8c97e34a74132", "custom_id": "Fentanyl-Labetalol-Metoprolol-Pirbuterol-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "87b64db642a8d0acb884e07f284fe272", "body": {"id": "chatcmpl-BNOSz2xPGpyqKfpdHC1BKRK7KruUm", "object": "chat.completion", "created": 1744915293, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for conditions that require both a cardioselective \u03b21-adrenergic antagonist commonly used for angina and hypertension, and a short-acting \u03b22 adrenoreceptor agonist administered via a breath-activated inhaler for asthma, develops erythema as a side effect of this drug combination. Based on the interactions among these drug classes, which inhaled medication is most likely contributing to this erythema when taken with the \u03b21-blocker?\n\nAnswer: Pirbuterol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1071, "completion_tokens": 103, "total_tokens": 1174, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b70d3388190b77b893f632a8d89", "custom_id": "Gabapentin-Ketorolac-Ticlopidine-Tirofiban-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "e31a9d7d129c9e8591db465e4c78fdba", "body": {"id": "chatcmpl-BNOSvM0HbpskHlwCxgwLm2MMrsV4A", "object": "chat.completion", "created": 1744915289, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient is being treated for stroke prevention with an antiplatelet agent from the thienopyridine class, which acts as an ADP receptor inhibitor but carries a risk of neutropenia and thrombotic microangiopathy. If this patient is given another antiplatelet drug that directly inhibits fibrinogen binding to GP IIb/IIIa and was developed through pharmacophore-based virtual screening, which drug-drug interaction specifically increases the risk of thrombocytopenia?\n\nAnswer: Tirofiban", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1153, "completion_tokens": 108, "total_tokens": 1261, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b70e37c8190a385347fce27b859", "custom_id": "Temazepam-Megestrol-Desloratadine-Telithromycin-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "655ccfa7a2e5d2301180037fd7181abd", "body": {"id": "chatcmpl-BNOSwfmERalUEpFnndxjNyjRUnC1p", "object": "chat.completion", "created": 1744915290, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for allergies with a tricyclic H1 inverse agonist that is an active metabolite of loratadine reports developing a sinus headache after starting a course of an antibiotic that is the first ketolide, used for community-acquired pneumonia and marketed under a name referencing its ketogroup modification. Which antibiotic was most likely added to the regimen?\n\nAnswer: Telithromycin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 946, "completion_tokens": 82, "total_tokens": 1028, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b70f67081908ef39f498ea76d51", "custom_id": "Candesartan-mitomycin C-vincristine-Torasemide-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "ffeb1e757486e5cf9cef0e7ae96377af", "body": {"id": "chatcmpl-BNOSyoSzXkn0qOv52nZLZDxiXs2Dt", "object": "chat.completion", "created": 1744915292, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA loop diuretic belonging to the sulfonamide class, used to treat fluid overload in heart, liver, or kidney disease (but less often for hypertension), is known to interact with a vinca alkaloid chemotherapy agent derived from Catharanthus roseus\u2014an agent notable for its neurotoxicity and therapeutic role in various leukemias and lymphomas\u2014resulting in increased risk of unspecified drug toxicity. Which drug is this diuretic?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 888, "completion_tokens": 100, "total_tokens": 988, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b7106a48190a097de25d50b6ebb", "custom_id": "Efavirenz-Lamivudine-Metoprolol-Acitretin-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "1371f719c6544c9e3d209aa186e957e9", "body": {"id": "chatcmpl-BNOSv7fkwHmQWiFhACPYIprY6LDct", "object": "chat.completion", "created": 1744915289, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with hypertension and a history of migraines is being treated with a cardioselective \u03b21-adrenergic antagonist known for its negative chronotropic and inotropic effects. If this patient is prescribed a second-generation oral retinoid, typically reserved for severe and treatment-resistant psoriasis due to its risk of severe side effects, which can induce keratinocyte differentiation and reduce epidermal hyperplasia, what medication combination may result in loss of weight as a drug-drug interaction outcome?\n\nAnswer: Acitretin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1170, "completion_tokens": 105, "total_tokens": 1275, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b711a308190a64248aab45f636e", "custom_id": "Furosemide-Zolpidem-vincristine-Torasemide-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "b27f989cfded360cc8afc98e7741bb0f", "body": {"id": "chatcmpl-BNOSwLqkaQINO4bFPjpUD0iDJ5Vae", "object": "chat.completion", "created": 1744915290, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA vinca alkaloid chemotherapy agent, which must be administered intravenously due to fatal neurotoxic risk if given intrathecally and is known for causing peripheral neuropathy and disrupting microtubule assembly, is reported to result in unspecified drug toxicity when used in combination with a sulfonamide loop diuretic that is frequently prescribed for fluid overload related to heart, kidney, or liver disease and is available both orally and intravenously. Which diuretic is associated with this interaction?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1306, "completion_tokens": 108, "total_tokens": 1414, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b7129208190b206225e5a2b6230", "custom_id": "Diazepam-Ketoprofen-oxybutynin-Zaleplon-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "5409f0812b89e42b6618865b9dbe0531", "body": {"id": "chatcmpl-BNOSydQqMypCFmTudNCBTkQFv5jV4", "object": "chat.completion", "created": 1744915292, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for overactive bladder with an anticholinergic agent that can be administered orally or transdermally is also prescribed a sedative and hypnotic from the pyrazolopyrimidine class to manage insomnia. According to documented drug-drug interactions, which sedative agent may increase the risk of apoplexy when used in combination with the aforementioned antimuscarinic medication?\n\nAnswer: Zaleplon", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1045, "completion_tokens": 89, "total_tokens": 1134, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b7138c88190ae755a6158a027e6", "custom_id": "Naproxen-Capecitabine-Desloratadine-Telithromycin-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "3f679741ebfd7ccce2d5bba1c821f2f5", "body": {"id": "chatcmpl-BNOT0hAlDQCbb55grvCNMGgtIwV5O", "object": "chat.completion", "created": 1744915294, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA tricyclic H1 inverse agonist, commonly used to treat allergies and available on the market since 2001, can cause a specific adverse effect related to sinus headaches when taken concurrently with a ketolide antibiotic that is a semi-synthetic erythromycin derivative, notable for being the first of its class and having had its approved uses restricted by the FDA due to safety concerns. Based on this interaction, which antibiotic is involved?\n\nAnswer: Telithromycin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1053, "completion_tokens": 95, "total_tokens": 1148, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b7149248190b8d9491c10612c63", "custom_id": "Famotidine-Lamivudine-Metoprolol-Bimatoprost-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "dbc76d4c35600a22ed190a87628a8eb8", "body": {"id": "chatcmpl-BNOT2LWXldPFbA7adOzn5PmSR7gvN", "object": "chat.completion", "created": 1744915296, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated with a cardioselective \u03b21-adrenergic receptor antagonist that requires individualized dosing due to CYP2D6 variability and is used for conditions such as hypertension and angina, begins to experience exertional shortness of breath after starting an ophthalmic prostaglandin analog indicated primarily for glaucoma and enhancement of eyelash growth, which is administered via eye drops and is known to cause ocular side effects. Which newly added medication is most likely contributing to this exertional dyspnea as a result of its interaction with the \u03b21-blocker?\n\nAnswer: Bimatoprost", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1140, "completion_tokens": 122, "total_tokens": 1262, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b71585881909b99a5b15b8df1bb", "custom_id": "acetazolamide-Haloperidol-indometacin-Torasemide-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "f5f6fa5679d5f220dad0ebf9e4287a1e", "body": {"id": "chatcmpl-BNOT3DaURTLMMh0IkrqDENK2vdy8u", "object": "chat.completion", "created": 1744915297, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated with a nonsteroidal anti-inflammatory drug that reduces prostaglandin synthesis and is on the list of essential medicines subsequently develops increased arterial pressure of unspecified type after starting a medication primarily used to treat fluid overload related to heart, kidney, or liver disease by reducing renal sodium reabsorption. Which drug is most likely responsible for this interaction with the NSAID?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1162, "completion_tokens": 85, "total_tokens": 1247, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b7167bc8190afa1788affe3071b", "custom_id": "Candesartan-Citalopram-nevirapine-oxybutynin-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "68289dffd55b099f944629893bfb57ea", "body": {"id": "chatcmpl-BNOSw5p9fcrInL9KFx8R3ZD7cMo3F", "object": "chat.completion", "created": 1744915290, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated with a non-nucleoside reverse transcriptase inhibitor known for its use in HIV-1 management, who experiences emesis after adding a medication used primarily to alleviate overactive bladder symptoms via potent antimuscarinic activity, is most likely experiencing a drug interaction with which medication?\n\nAnswer: oxybutynin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1157, "completion_tokens": 69, "total_tokens": 1226, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b7178188190a09350cf2ee5814c", "custom_id": "Zafirlukast-Zolpidem-vincristine-Torasemide-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "29a0108881a15059cb1c0dfdeb823a4d", "body": {"id": "chatcmpl-BNOSwalIVULHsygXWXkXgLVBfyJ10", "object": "chat.completion", "created": 1744915290, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, recognized as a sulfonamide loop diuretic used primarily for managing fluid overload in heart failure, kidney, or liver disease, is associated with increased risk of unspecified drug toxicity when co-administered with a vinca alkaloid chemotherapeutic that acts as a mitotic inhibitor and can cause neuropathy and gastrointestinal stasis?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1249, "completion_tokens": 78, "total_tokens": 1327, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b7188008190b153f0788b6b8dae", "custom_id": "Lamotrigine-Oxaprozin-Sildenafil-Acamprosate-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "9631df4f24aebf756d9ca63811c55717", "body": {"id": "chatcmpl-BNOSz2ZxxGCYxdZJah4dJGNlfCkVp", "object": "chat.completion", "created": 1744915293, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nAn alcohol craving-reduction agent, which primarily stabilizes brain chemical signaling disrupted during alcohol withdrawal and lists diarrhea as its most common side effect, may lead to weight loss when used in combination with a selective PDE5 inhibitor for erectile dysfunction and pulmonary arterial hypertension. Which drug is this?\n\nAnswer: Acamprosate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1068, "completion_tokens": 65, "total_tokens": 1133, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b7197e48190abb99577850d99d0", "custom_id": "Cetirizine-Dipyridamole-Sildenafil-Zaleplon-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "34bc96c6e860f0b9cda5726c39eab295", "body": {"id": "chatcmpl-BNOSxC8Y9vZQ6B1pnS6sRm8uI9zYL", "object": "chat.completion", "created": 1744915291, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA selective PDE5 inhibitor used primarily for erectile dysfunction and pulmonary arterial hypertension, which can cause severe hypotension if combined with nitrates, has an interaction with a sedative-hypnotic nonbenzodiazepine of the pyrazolopyrimidine class used for insomnia that results in apoplexy. Which drug, described above, when taken alongside the PDE5 inhibitor, leads to this interaction?\n\nAnswer: Zaleplon", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 966, "completion_tokens": 90, "total_tokens": 1056, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b71a7b08190ac97da567daa24eb", "custom_id": "Temazepam-Megestrol-Desloratadine-Darunavir-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "d67114bf2eaf24db4c5b34ca18cd3281", "body": {"id": "chatcmpl-BNOSw8zGH957c2qPq6RaNtnJakIv9", "object": "chat.completion", "created": 1744915290, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for allergies with a non-sedating tricyclic H1 inverse agonist, which is the active metabolite of loratadine, develops acute pancreatitis after starting a new antiretroviral protease inhibitor that requires boosting with ritonavir or cobicistat for optimal HIV-1 suppression. Which newly added medication is most likely responsible for this adverse event according to known drug interaction data?\n\nAnswer: Darunavir", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 986, "completion_tokens": 91, "total_tokens": 1077, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b71b75481909d8aca6ae3919e3d", "custom_id": "Diazepam-Ketoprofen-oxybutynin-Pirbuterol-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "56dec85a6fffbb22bb490786caf5a285", "body": {"id": "chatcmpl-BNOSxd13NpW4e1uvUSBy41dVVS8vw", "object": "chat.completion", "created": 1744915291, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, identified as a short-acting \u03b22 adrenoreceptor agonist available as a breath-activated metered-dose inhaler used for asthma, is associated with an increased risk of apoplexy when taken in combination with a potent antimuscarinic agent commonly used to manage overactive bladder symptoms?\n\nAnswer: Pirbuterol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1041, "completion_tokens": 70, "total_tokens": 1111, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b71c83481909b4eec1f99ac5206", "custom_id": "acetazolamide-Diazepam-Ibuprofen-Modafinil-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "7e26d2f54613269e196fcaff4aa3111f", "body": {"id": "chatcmpl-BNOSyDSlmcWnx2pX8BggcYHuBY4ld", "object": "chat.completion", "created": 1744915292, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient initially treated with a carbonic anhydrase inhibitor for glaucoma, who then develops pain requiring the addition of an anxiolytic that acts by enhancing GABA_A receptor activity, later experiences gastric inflammation treated with a cyclooxygenase-inhibiting anti-inflammatory, and subsequently presents with adenopathy as a new side effect. Based on the described sequence of drug interactions, which central nervous system stimulant, primarily prescribed to promote wakefulness in sleep disorders, is most likely implicated in this development?\n\nAnswer: Modafinil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1288, "completion_tokens": 107, "total_tokens": 1395, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b71dadc819096e84e425279c2a1", "custom_id": "Aciclovir-Doxazosin-Pamidronic acid-thiotepa-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "0803646e5267e50dccb1c85328c111f0", "body": {"id": "chatcmpl-BNOT10WOTAogMKZ4a91p1t4kzgGlU", "object": "chat.completion", "created": 1744915295, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with osteoporosis who is prescribed a nitrogen-containing bisphosphonate and subsequently receives an organophosphorus anti-cancer agent develops erythema as a result of the drug-drug interaction between these two agents. Based on this information, which agent is the anti-cancer medication involved in this interaction?\n\nAnswer: thiotepa", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 821, "completion_tokens": 70, "total_tokens": 891, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b71ee94819089bf366e90a18a51", "custom_id": "Alprazolam-Bumetanide-vincristine-Torasemide-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "4c4ac3e4f11fa2dac49e88937872230a", "body": {"id": "chatcmpl-BNOT2FY3fTCE8YELdQ3h0jBuusOlv", "object": "chat.completion", "created": 1744915296, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA certain mitotic inhibitor vinca alkaloid indicated for leukemias, lymphomas, and other malignancies is well known for causing neuropathic side effects and demands intravenous administration due to risk of fatal intrathecal toxicity. When co-administered with a sulfonamide loop diuretic that treats edema from heart failure, kidney, or liver disease, and is not the primary choice for hypertension, what diuretic is associated with an increased risk of unspecified drug toxicity in this context?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1216, "completion_tokens": 109, "total_tokens": 1325, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b71fd108190b495fd47d23ba505", "custom_id": "Naproxen-Orphenadrine-Temazepam-Cinacalcet-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "1c519437c190c7bd96e8abca22a1060e", "body": {"id": "chatcmpl-BNOSxPzjbrm56FfNqfdGnT1FKBl4U", "object": "chat.completion", "created": 1744915291, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA benzodiazepine hypnotic, known for its rapid onset of sedative effects and allosteric modulation of GABA-A receptors, may lead to constipation when taken together with a calcimimetic agent that allosterically activates calcium-sensing receptors to treat parathyroid disorders. Which is the calcimimetic drug involved in this interaction?\n\nAnswer: Cinacalcet", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1114, "completion_tokens": 80, "total_tokens": 1194, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b720c208190afc01df609ddbe04", "custom_id": "Temazepam-Zafirlukast-Duloxetine-Acamprosate-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "ee72d5a32dc8af8595bb65c7d80252a0", "body": {"id": "chatcmpl-BNOT0eO04ZKb80GxsByCsD0IxqPhF", "object": "chat.completion", "created": 1744915294, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient prescribed a serotonin\u2013norepinephrine reuptake inhibitor commonly used for conditions such as depression and neuropathic pain begins to experience nausea after initiating therapy with an agent included on the World Health Organization's List of Essential Medicines, which is utilized to help reduce cravings in alcoholism by stabilizing neurochemical disruptions during alcohol withdrawal. Based on documented drug-drug interaction profiles, which medication is most likely responsible for this exacerbation of nausea when co-administered with the antidepressant?\n\nAnswer: Acamprosate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1195, "completion_tokens": 107, "total_tokens": 1302, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b721c108190a8f40c6c3b031648", "custom_id": "Tramadol-Ziprasidone-Desloratadine-Telithromycin-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "1dc8e3fe70563991eb10f9211215604c", "body": {"id": "chatcmpl-BNOSyLEwBaINqqew1wUGMRALhyTKp", "object": "chat.completion", "created": 1744915292, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient taking an oral tricyclic H1 inverse agonist to manage allergic symptoms develops a sinus headache after starting a semi-synthetic erythromycin derivative antibiotic that is approved for mild to moderate community acquired pneumonia but whose use was restricted in the US due to safety concerns. Which drug is most likely responsible for this interaction?\n\nAnswer: Telithromycin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1066, "completion_tokens": 72, "total_tokens": 1138, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b722b48819090450a8b92fbf026", "custom_id": "Fentanyl-Labetalol-Metoprolol-Acitretin-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "f4dc19d32bce3ff9c811e9ad450aad50", "body": {"id": "chatcmpl-BNOT05gk681dDVqWdgMasUXVKz3Jz", "object": "chat.completion", "created": 1744915294, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for cardiovascular conditions with a cardioselective \u03b21-adrenergic receptor antagonist, known for its role in managing hypertension and angina and metabolized by cytochrome P450 2D6, develops loss of weight when co-administered with a second-generation oral retinoid that is primarily reserved for severe, treatment-resistant cases of psoriasis. Based on their documented drug-drug interaction, which medication used for psoriasis is implicated in this adverse effect?\n\nAnswer: Acitretin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1178, "completion_tokens": 105, "total_tokens": 1283, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b723a6c8190907324870b48ad02", "custom_id": "Aciclovir-Efavirenz-oxybutynin-Zaleplon-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "e68f4516e2a3c2ccf03d8c4ec9e15e17", "body": {"id": "chatcmpl-BNOT2AFdqJUS6fpoelWYTkg715kL4", "object": "chat.completion", "created": 1744915296, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for overactive bladder symptoms with a potent antimuscarinic agent, which is known to occasionally cause thermoregulatory dysfunction such as heat stroke, and who adds a sedative-hypnotic from the pyrazolopyrimidine class (developed by King Pharmaceuticals and approved in the US in 1999) is at increased risk of what outcome according to drug-drug interaction data?\n\nAnswer: Zaleplon", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1050, "completion_tokens": 93, "total_tokens": 1143, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b724b788190bcf22325191f882a", "custom_id": "Diazepam-Gemfibrozil-Sildenafil-Acamprosate-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "3f26b6ddf114561798e6f66f36c577f9", "body": {"id": "chatcmpl-BNOT4nPUMlL74NqpD6l4qMsKxx5Xq", "object": "chat.completion", "created": 1744915298, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for pulmonary arterial hypertension with a medication that selectively inhibits phosphodiesterase type 5, thus promoting vasodilation, begins to experience unexplained loss of weight after starting a new therapy for alcohol dependence. This new adjunct medication is specifically used to reduce cravings in alcoholism by stabilizing neural signaling disrupted during withdrawal, though it is most effective when combined with psychosocial support. Based on documented drug-drug interaction profiles, which medication for alcohol dependence is most likely responsible for the observed weight loss when administered with the pulmonary vasodilator?\n\nAnswer: Acamprosate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1251, "completion_tokens": 119, "total_tokens": 1370, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68014b725cdc81908593925c4a09aff0", "custom_id": "Aciclovir-Efavirenz-Lamivudine-Metoprolol-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "4edfbfc3a9514c6e3bc464d2e6994c1a", "body": {"id": "chatcmpl-BNOSzR1LpEertf0tP2mS9JguxIhBr", "object": "chat.completion", "created": 1744915293, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient currently being treated for chronic hepatitis B and HIV infection with a nucleoside reverse transcriptase inhibitor, known for potential risks of lactic acidosis and hepatitis B flare, begins therapy for migraine prophylaxis and hypertension with a cardioselective \u03b21-adrenergic antagonist that requires individualized dosing due to CYP2D6 metabolic variability. Based on documented drug-drug interaction profiles, which new medication is associated with the emergence of dysarthria when combined with the patient's existing antiretroviral regimen?\n\nAnswer: Metoprolol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1162, "completion_tokens": 111, "total_tokens": 1273, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b726d0c8190ab956c5ebae88285", "custom_id": "Citalopram-nevirapine-Ofloxacin-Oxaprozin-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "606684f105af18ddd4ea1f91923b5cbb", "body": {"id": "chatcmpl-BNOSzxgiMqZxqX0YnIjGcjcfTK5Uv", "object": "chat.completion", "created": 1744915293, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question: A medication widely prescribed as an oral or intravenous antimicrobial for bacterial infections, including pneumonia and urinary tract infections, can, when co-administered with a nonsteroidal anti-inflammatory drug used to relieve inflammation and pain in arthritic conditions, lead to gastric inflammation as a drug interaction. Which drug used for arthritis is implicated in this adverse interaction?\n\nAnswer: Oxaprozin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1113, "completion_tokens": 77, "total_tokens": 1190, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b728cc081908717c99100cf87aa", "custom_id": "Celecoxib-chlortalidone-Sildenafil-Zaleplon-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "686fe4ca32b40acd1035bb8244c9e322", "body": {"id": "chatcmpl-BNOT1GJ8P0ugZfqxNZdr2iuZTmgYy", "object": "chat.completion", "created": 1744915295, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient who is currently prescribed a selective phosphodiesterase type 5 inhibitor for erectile dysfunction and pulmonary arterial hypertension develops apoplexy after being started on a short-acting nonbenzodiazepine pyrazolopyrimidine sedative-hypnotic used for insomnia. Based on known drug-drug interactions, which medication most likely caused this adverse event when combined with the PDE5 inhibitor?\n\nAnswer: Zaleplon", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1202, "completion_tokens": 89, "total_tokens": 1291, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b729d7c81908b1b2e492d33d10c", "custom_id": "Temazepam-Zafirlukast-Rosiglitazone-Bimatoprost-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "b05a8f58824b1af1c60a40aceb627831", "body": {"id": "chatcmpl-BNOT4rIciO5kYc6fm70jDm2viyb3x", "object": "chat.completion", "created": 1744915298, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with a history of type 2 diabetes managed with a thiazolidinedione PPAR\u03b3 agonist\u2014who is also being prescribed a prostaglandin analog ophthalmic agent commonly used to lower intraocular pressure in glaucoma and occasionally to promote eyelash growth\u2014develops adenopathy following the initiation of this eye drop. Based on documented drug-drug interaction data among these agents, which medication most likely contributed to the emergence of adenopathy when used with the oral antidiabetic drug?\n\nAnswer: Bimatoprost", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1170, "completion_tokens": 109, "total_tokens": 1279, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b72ad4c819083adda076100f00d", "custom_id": "Famotidine-Lamivudine-Metoprolol-Fulvestrant-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "e513350ac90cd9f097deda7552c5b9ce", "body": {"id": "chatcmpl-BNOSyUVEqTATdBr71oLTdca4NOlNf", "object": "chat.completion", "created": 1744915292, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA cardioselective \u03b21-adrenergic blocker commonly prescribed for hypertension and arrhythmias, when administered concomitantly with which intramuscularly given antiestrogenic agent used for hormone receptor-positive metastatic breast cancer, may increase the risk of upper abdominal pain as described by their documented drug-drug interaction?\n\nAnswer: Fulvestrant", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1111, "completion_tokens": 73, "total_tokens": 1184, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b72bcd4819083f4a1edf403fe08", "custom_id": "Alprazolam-Lidocaine-Pamidronic acid-thiotepa-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "74ee674bcd934b60bcb670a8ed0b5832", "body": {"id": "chatcmpl-BNOSy5HmRFlN5uuOAhqcyPpTJ7TW7", "object": "chat.completion", "created": 1744915292, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nAmong the drugs described, which compound, characterized as an organophosphorus anti-cancer agent, is associated with the onset of erythema when used in combination with a nitrogen-containing bisphosphonate developed to prevent osteoporosis and approved in 1987?\n\nAnswer: thiotepa", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 980, "completion_tokens": 60, "total_tokens": 1040, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b72cc6081908e3430179d820a5f", "custom_id": "Ofloxacin-Oxaprozin-Sildenafil-Zaleplon-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "4d95c8d52179a2a8977f29d2e546e962", "body": {"id": "chatcmpl-BNOT0tn5uhZGmOvUKwJgOCygclrMC", "object": "chat.completion", "created": 1744915294, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient treated for erectile dysfunction and pulmonary arterial hypertension with a selective phosphodiesterase type 5 inhibitor experiences a rare but severe occurrence of apoplexy after taking an additional dose of a nonbenzodiazepine sedative-hypnotic from the pyrazolopyrimidine class for insomnia. Based on the known drug-drug interactions, which medication was most likely co-administered with the phosphodiesterase inhibitor to precipitate this adverse event?\n\nAnswer: Zaleplon", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 956, "completion_tokens": 102, "total_tokens": 1058, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b72db9081908e6080934596019c", "custom_id": "alendronic acid-Dipyridamole-oxybutynin-Zaleplon-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "fb9197f77e8cf0cc875313f14dfa9385", "body": {"id": "chatcmpl-BNOT4N4B69yo7NDShUTWrBy0nEIjY", "object": "chat.completion", "created": 1744915298, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA medication used as a first-line treatment for overactive bladder due to its antimuscarinic properties, which requires caution owing to potential adverse effects like urinary retention and thermoregulatory dysfunction, has been linked to an increased risk of apoplexy when taken in combination with a certain sedative-hypnotic agent indicated for insomnia. Based on the described drug-drug interaction, which sedative-hypnotic drug is implicated in this adverse event?\n\nAnswer: Zaleplon", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 909, "completion_tokens": 101, "total_tokens": 1010, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b72eb108190a6019725b9dec29c", "custom_id": "Furosemide-Lamotrigine-Oxaprozin-Sildenafil-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "13bf1f20116ed85d5f26a1a7951a7b35", "body": {"id": "chatcmpl-BNOT0J4KHlAPe8MvM63jVC44UfFIN", "object": "chat.completion", "created": 1744915294, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA medication commonly used to relieve inflammation and joint pain in arthritis patients is known to cause gastric inflammation when taken together with a phosphodiesterase type 5 inhibitor that enhances nitric oxide-mediated vasodilation to treat erectile dysfunction and pulmonary arterial hypertension. If a patient on the arthritis medication develops gastric inflammation after adding another agent with rapid onset of action that can cause facial flushing, headaches, and rare vision impairment, which medication was most likely added?\n\nAnswer: Sildenafil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1153, "completion_tokens": 94, "total_tokens": 1247, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b72fa908190b8ec576b7ca3489a", "custom_id": "Candesartan-Citalopram-nevirapine-Ofloxacin-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "5e3ac3e1a7e6215e3061e5b9f43426a8", "body": {"id": "chatcmpl-BNOT2MSOetrHXHfAShjbTkj4WojVk", "object": "chat.completion", "created": 1744915296, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question: A patient undergoing antiretroviral therapy with a non-nucleoside reverse transcriptase inhibitor known to cause serious rash and liver problems develops anogenital warts after starting a DNA synthesis inhibitor from the fluoroquinolone class, which is indicated for bacterial infections like pneumonia and urinary tract infections. Considering the interactions among these treatments, which drug is most likely associated with the development of anogenital warts in this patient?\n\nAnswer: Ofloxacin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1105, "completion_tokens": 93, "total_tokens": 1198, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b7311148190aafa4cae4b184552", "custom_id": "Bumetanide-Fenofibrate-Modafinil-Pamidronic acid-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "7fa36b90dcd62910e2a1e168f6cdc48d", "body": {"id": "chatcmpl-BNOT3KQJUZ5hJ7xB2wsYK3hLVQi7h", "object": "chat.completion", "created": 1744915297, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, approved for medical use in 1987 and classified as a nitrogen-containing bisphosphonate used in the prevention of osteoporosis, is known to interact with a CNS stimulant indicated for narcolepsy such that their combined use may lead to elevated blood pressure?\n\nAnswer: Pamidronic acid", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1062, "completion_tokens": 62, "total_tokens": 1124, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b73201c8190bb6da8d080937760", "custom_id": "Cimetidine-Citalopram-nevirapine-oxybutynin-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "0517b69937e1fd821522ddfdfc574e0e", "body": {"id": "chatcmpl-BNOT8orAr4CKwFOHnl4p5esXs4Ngq", "object": "chat.completion", "created": 1744915302, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for HIV-1 with a non-nucleoside reverse transcriptase inhibitor may experience emesis if they also begin therapy with an anticholinergic medication widely prescribed for overactive bladder symptoms and known to cause adverse effects such as xerostomia and urinary retention. Which drug, when added to the HIV therapy, is associated with this increased risk of emesis?\n\nAnswer: oxybutynin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1206, "completion_tokens": 86, "total_tokens": 1292, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68014b732f4081909dcefb9cde3ef27c", "custom_id": "alendronic acid-Dipyridamole-oxybutynin-Pirbuterol-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "22a2148cbd477138320c771a212d3f85", "body": {"id": "chatcmpl-BNOT0D9j2yqJr6l4NdoR3ygav7zke", "object": "chat.completion", "created": 1744915294, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA medication commonly prescribed for overactive bladder due to its potent antimuscarinic effects, which can cause adverse effects such as urinary retention and thermoregulation issues, may lead to apoplexy when taken together with a short-acting \u03b22 adrenoreceptor agonist used via a breath-activated metered-dose inhaler for asthma. Which medication is this bronchodilator?\n\nAnswer: Pirbuterol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 905, "completion_tokens": 84, "total_tokens": 989, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b733fb08190a8f3e13ea7b9e3ee", "custom_id": "Doxazosin-Dexpramipexole-Ticlopidine-Tirofiban-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "8c900e500efc6b93a71c2ce760343087", "body": {"id": "chatcmpl-BNOT0CbehtKDRVOitGMil8wneEJ4e", "object": "chat.completion", "created": 1744915294, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with a history of thrombotic stroke, currently managed with an antiplatelet drug from the thienopyridine family that acts as an ADP receptor inhibitor, begins therapy with a generic antiplatelet agent that works by inhibiting the interaction between fibrinogen and platelet glycoprotein IIb/IIIa receptors. According to documented drug-drug interactions, what new medication may, when combined with the patient\u2019s current thienopyridine antiplatelet therapy, increase the risk of thrombocytopenia?\n\nAnswer: Tirofiban", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 935, "completion_tokens": 120, "total_tokens": 1055, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b734f548190885bfeaace14bef2", "custom_id": "alendronic acid-Efavirenz-Lamivudine-Metoprolol-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "995126dc0ab98fbd6befdfb516158b5c", "body": {"id": "chatcmpl-BNOT2nkADjbgIGammSov6DSF2uV6l", "object": "chat.completion", "created": 1744915296, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for chronic hepatitis B and HIV with a nucleoside reverse transcriptase inhibitor that can cause gastrointestinal disturbances and lactic acidosis develops symptoms of dysarthria upon coadministration with a cardioselective \u03b21-adrenergic antagonist used for angina, hypertension, and migraine prophylaxis, which exhibits variable metabolism due to CYP2D6 differences. Which cardiovascular medication is likely involved in this interaction?\n\nAnswer: Metoprolol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1167, "completion_tokens": 94, "total_tokens": 1261, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b73630c8190b05ad22c03661bce", "custom_id": "Naproxen-Cetirizine-Pyridostigmine-Telithromycin-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "f98370e626fa8221ee3b2690e83ff0ae", "body": {"id": "chatcmpl-BNOT4g66Jng9MsbeBJMx5Xgc2kE7N", "object": "chat.completion", "created": 1744915298, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question: A patient with myasthenia gravis who is being treated with a quaternary ammonium acetylcholinesterase inhibitor for symptomatic relief develops dysarthria after starting an antibiotic used for community acquired pneumonia that is a semi-synthetic erythromycin derivative featuring a ketogroup substitution, carbamate ring, and alkyl-aryl moiety for improved acid-stability. Which drug is most likely responsible for this interaction?\nAnswer: Telithromycin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1276, "completion_tokens": 93, "total_tokens": 1369, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b7372c88190a471922f3eee4750", "custom_id": "Rofecoxib-Zolpidem-vincristine-Torasemide-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "46bd04dde99702fda302453ee4630e77", "body": {"id": "chatcmpl-BNOT5OjBj2ZuzXJqdMN7tgNWwfCeJ", "object": "chat.completion", "created": 1744915299, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient undergoing treatment with an intravenous vinca alkaloid effective against leukemia and neuroblastoma develops drug toxicity of unspecified origin after being administered a loop diuretic from the sulfonamide class, commonly used for fluid overload in heart failure and kidney disease, and which was among the 200 most commonly prescribed medications in the US in 2022. Based on the described drug-drug interaction, which medication is the loop diuretic responsible for this interaction?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1275, "completion_tokens": 101, "total_tokens": 1376, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b7384408190bea6efe3a2442657", "custom_id": "Candesartan-Fenofibrate-Modafinil-Bimatoprost-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "95d2525eb226b7eac3c6982ee69b2460", "body": {"id": "chatcmpl-BNOT897i3HKykp57jfGdzQuBymTqp", "object": "chat.completion", "created": 1744915302, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nIn a clinical scenario involving a central nervous system stimulant commonly prescribed for narcolepsy and known to cause insomnia and potential psychiatric effects, which is pharmacologically unrelated to the agent that is an angiotensin receptor blocker used for hypertension, concurrent administration with an ophthalmic prostaglandin analog\u2014approved for lowering intraocular pressure in glaucoma patients and occasionally employed to enhance eyelash growth\u2014may result in the development of nocturia as described in recent interaction literature. Which medication, characterized by causing reversible eye color changes and used primarily as an eye drop, is implicated in this interaction?\n\nAnswer: Bimatoprost", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1044, "completion_tokens": 124, "total_tokens": 1168, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b739430819097474195f36a375f", "custom_id": "Amlodipine-Ketoprofen-Pamidronic acid-thiotepa-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "d4486db317d7c2343df1814c6c3434bf", "body": {"id": "chatcmpl-BNOT0NisbFPMYwtXatK8Y4aTp3qWJ", "object": "chat.completion", "created": 1744915294, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA bisphosphonate used to prevent osteoporosis can cause erythema when taken with which anti-cancer medication that is an organophosphorus compound with the formula (C2H4N)3PS?\n\nAnswer: thiotepa", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 691, "completion_tokens": 51, "total_tokens": 742, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b73a41881908925788cc2387c15", "custom_id": "Aciclovir-Lidocaine-vincristine-Torasemide-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "89f6af2ecff05568b15014ee04246d8b", "body": {"id": "chatcmpl-BNOT0gmePTORa6h0nnwYWuY2Je5mG", "object": "chat.completion", "created": 1744915294, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA chemotherapeutic agent known for causing peripheral neuropathy and disrupting microtubule assembly can develop nonspecific drug toxicity when co-administered with which medication indicated for fluid overload due to heart failure, kidney, or liver disease, and acts as a sulfonamide loop diuretic by inhibiting sodium reabsorption in the kidneys?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1218, "completion_tokens": 77, "total_tokens": 1295, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b73b3d081908ece7faf9d8eee1c", "custom_id": "alendronic acid-Efavirenz-oxybutynin-Pirbuterol-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "617afd9d6d87aba16e10df05dda140e6", "body": {"id": "chatcmpl-BNOT2eqoPfEsREiZXyIwotjUA0zGf", "object": "chat.completion", "created": 1744915296, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient who is being treated for overactive bladder with a potent anticholinergic agent known for potential adverse effects such as xerostomia, urinary retention, and heat stroke might experience a severe neurological event if given an inhaled short-acting \u03b22 adrenoreceptor agonist that was introduced to clinical use in the early 1980s for asthma management. Which medication is associated with this interaction?\n\nAnswer: Pirbuterol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1051, "completion_tokens": 89, "total_tokens": 1140, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b73c3e48190843133294f9efbd0", "custom_id": "Ranitidine-Zolpidem-vincristine-Torasemide-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "f492dc17d102ce6330f9226b120a4cdc", "body": {"id": "chatcmpl-BNOT2NCvTL6jcHtXcdYp6gZoLprDS", "object": "chat.completion", "created": 1744915296, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nGiven a scenario where a mitotic inhibitor derived from Catharanthus roseus, known for treating leukemias and lymphomas but carrying significant neurotoxic and myelosuppressive risks, is co-administered with a sulfonamide loop diuretic used to manage edema in heart, kidney, or liver disease, which drug is associated with potentiating the nonspecific toxic effects of the chemotherapeutic agent as described in their known interaction?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1314, "completion_tokens": 98, "total_tokens": 1412, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b73d3d08190948d5c3c9a8e2ff6", "custom_id": "Carvedilol-Metolazone-Dexpramipexole-Ticlopidine-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "519cc3977ccbb04b8165994248727eaa", "body": {"id": "chatcmpl-BNOT4uEEOzsmx2rNkxJrTke3GfBVp", "object": "chat.completion", "created": 1744915298, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA first-in-class oral investigational medication that lowers blood and tissue eosinophils and has shown significant reductions in blood eosinophil counts across clinical trials may interact with another drug from the thienopyridine family, primarily used to reduce the risk of thrombotic strokes in patients not suited for aspirin, to produce which side effect according to their known interaction?\n\nAnswer: Ticlopidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1005, "completion_tokens": 83, "total_tokens": 1088, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b73e7dc8190a930039769ca8b42", "custom_id": "Celecoxib-Labetalol-Metoprolol-Bimatoprost-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "bda45947eb3897510c5a3d967b2dcda2", "body": {"id": "chatcmpl-BNOT59xRn1jQTMJknbx1cWpWRtEwL", "object": "chat.completion", "created": 1744915299, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with hypertension is being treated with a medication that blocks both \u03b1- and \u03b2-adrenergic receptors. If their regimen is intensified to include a cardioselective \u03b21-adrenergic antagonist often used post-myocardial infarction, and subsequently, an ocular prostaglandin analog is prescribed for open-angle glaucoma not adequately controlled by other agents, which added medication may increase the risk of exertional shortness of breath due to interaction with the \u03b21-adrenergic antagonist?\n\nAnswer: Bimatoprost", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1213, "completion_tokens": 109, "total_tokens": 1322, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68014b740194819099ac68b6d92079bc", "custom_id": "Aciclovir-Dipyridamole-Sildenafil-Acamprosate-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "58d239bb2146207e575047828c113b3e", "body": {"id": "chatcmpl-BNOT1UOEVFuyY8LDAHqXWCvU2xkPT", "object": "chat.completion", "created": 1744915295, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for pulmonary arterial hypertension with a medication that enhances nitric oxide-mediated vasodilation and is contraindicated with nitrates is considering adjunct therapy with another agent that is used to reduce cravings in individuals with alcohol use disorder by stabilizing brain chemical signaling during withdrawal. Which adjunct agent, when combined with the pulmonary medication, has been associated with loss of weight according to documented drug-drug interactions?\n\nAnswer: Acamprosate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 980, "completion_tokens": 89, "total_tokens": 1069, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b7416988190aa3bb9b48be55bf2", "custom_id": "Amlodipine-Metronidazole-Zolpidem-vincristine-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "f8bb2c2d84e50553959ad341f5c836fa", "body": {"id": "chatcmpl-BNOT30gK7I25oSwhWAbquNvjFeVr4", "object": "chat.completion", "created": 1744915297, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient suffering from cancer is being treated with an intravenously administered mitotic inhibitor derived from Catharanthus roseus, which disrupts microtubule assembly and is known for causing neuropathy and myelosuppression. If this agent is used concomitantly with a nonbenzodiazepine hypnotic agent that modulates the GABAA receptor to treat insomnia, which drug combination has been linked to the development of adenopathy?\n\nAnswer: vincristine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1253, "completion_tokens": 96, "total_tokens": 1349, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68014b742e50819097127e3fa9b328e2", "custom_id": "Methylphenidate-Modafinil-Pamidronic acid-thiotepa-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "949f0da310e736dd89ab50211b746dc1", "body": {"id": "chatcmpl-BNOT1EA53LaQXviR61x1GT5pbG0E8", "object": "chat.completion", "created": 1744915295, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, classified as an organophosphorus anti-cancer agent with the formula (C2H4N)3PS, is known to cause erythema when co-administered with a nitrogen-containing bisphosphonate that was patented in 1971 and approved in 1987 for osteoporosis prevention?\n\nAnswer: thiotepa", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 870, "completion_tokens": 72, "total_tokens": 942, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b743e888190a16aadf82925f3d7", "custom_id": "Diazepam-Gemfibrozil-Sildenafil-Zaleplon-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "e10e49f9a483d99838f4880d11eac080", "body": {"id": "chatcmpl-BNOT2FcP7iveblbf2erEdwu5E5ujx", "object": "chat.completion", "created": 1744915296, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with erectile dysfunction treated with a selective phosphodiesterase type 5 inhibitor, known to enhance nitric oxide-mediated vasodilation and used for pulmonary arterial hypertension, experiences apoplexy after combining this medication with a nonbenzodiazepine hypnotic of the pyrazolopyrimidine class approved for insomnia treatment in the late 1990s. Based on the drug-drug interaction described, which sedative agent is most likely implicated in this adverse reaction when taken with the vasodilator?\n\nAnswer: Zaleplon", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1152, "completion_tokens": 110, "total_tokens": 1262, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b744e6c81909b337be6828cc13d", "custom_id": "Naproxen-Temazepam-Zafirlukast-Rosiglitazone-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "951ebbc615d6915daa9231f7b81d4482", "body": {"id": "chatcmpl-BNOT4DRLdEgLleCmvC9EHobeLVn17", "object": "chat.completion", "created": 1744915298, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with asthma who is being treated with an orally administered leukotriene receptor antagonist that acts on cysteinyl leukotriene receptors to reduce airway inflammation is found to experience weight gain when a medication that improves insulin sensitivity through PPAR\u03b3 agonism is added to their regimen. Based on known drug-drug interactions, which medication used for glycemic control is most likely responsible for this increase in weight?\n\nAnswer: Rosiglitazone", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1242, "completion_tokens": 91, "total_tokens": 1333, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b745d7481909948ab788ff3c00c", "custom_id": "Naproxen-Cetirizine-Sildenafil-Zaleplon-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "989a935865e38aa024e5a61cbdf20da2", "body": {"id": "chatcmpl-BNOT7MX4KK8mpEwSxZUMJYFW9H32D", "object": "chat.completion", "created": 1744915301, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for erectile dysfunction with a selective phosphodiesterase type 5 inhibitor that promotes vasodilation and is also prescribed a sedative pyrazolopyrimidine-class hypnotic for insomnia may face an increased risk of a severe neurological event characterized by sudden loss of consciousness or paralysis. Which sedative-hypnotic, nonbenzodiazepine medication is implicated in this interaction?\n\nAnswer: Zaleplon", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1162, "completion_tokens": 89, "total_tokens": 1251, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b746ca4819098f0b85918601dd4", "custom_id": "alendronic acid-Dipyridamole-Sildenafil-Acamprosate-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "93e3700c2ba6a50273129962098bbc9f", "body": {"id": "chatcmpl-BNOTBpWkrWn0AS7vrafAWcXrKiyvH", "object": "chat.completion", "created": 1744915305, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA medication that is used to potentiate nitric oxide-mediated vasodilation for conditions like erectile dysfunction and pulmonary arterial hypertension\u2014known for its rapid onset and risk of severe hypotension with nitrates\u2014may cause loss of weight when taken with another drug that stabilizes disrupted brain signaling in alcohol withdrawal and is most commonly associated with diarrhea as a side effect. Which is this latter drug?\n\nAnswer: Acamprosate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 988, "completion_tokens": 85, "total_tokens": 1073, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b747c70819087e42e5080a56375", "custom_id": "Candesartan-Lamivudine-Metoprolol-Fulvestrant-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "b51c752f22ae59f8a03e72f555075ce8", "body": {"id": "chatcmpl-BNOTEyDgRBERH92htwx4puTqocdkO", "object": "chat.completion", "created": 1744915308, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with a history of cardiovascular disease is being managed with a cardioselective \u03b21-adrenergic antagonist known to require individualized dosing due to hepatic enzyme variability and associated with side effects such as insomnia and gastrointestinal disturbances. If this patient begins therapy with an antiestrogenic injectable agent that degrades estrogen receptors to treat hormone receptor-positive metastatic breast cancer after progression on endocrine therapy, which agent\u2014approved in the US in 2002\u2014might increase this patient's risk of experiencing upper abdominal pain through its interaction with the cardiovascular medication?\n\nAnswer: Fulvestrant", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1037, "completion_tokens": 116, "total_tokens": 1153, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b748e54819087ce2148485b4403", "custom_id": "Furosemide-Gemfibrozil-Sildenafil-Zaleplon-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "958162753d50cdac3771901ff7228009", "body": {"id": "chatcmpl-BNOT2I3o4LHbTFsPqs8eOfGQr2gud", "object": "chat.completion", "created": 1744915296, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient is receiving treatment for pulmonary arterial hypertension with a selective phosphodiesterase type 5 inhibitor, which enhances nitric oxide-mediated vasodilation. If this patient is also administered a sedative and hypnotic of the pyrazolopyrimidine class used for insomnia, which drug combination may specifically increase the risk of apoplexy according to documented drug-drug interactions?\n\nAnswer: Zaleplon", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1096, "completion_tokens": 84, "total_tokens": 1180, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b74a588819099de7703b882b4dc", "custom_id": "Temazepam-mitomycin C-vincristine-Torasemide-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "c8fa316e1471b19627cfa1d26d5b6b06", "body": {"id": "chatcmpl-BNOT20sVuNB5T8fBjXOZ4wu0H0aHd", "object": "chat.completion", "created": 1744915296, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with acute lymphoblastic leukemia undergoing treatment with a microtubule assembly\u2013inhibiting vinca alkaloid develops increased risk of a nonspecific drug toxicity when also prescribed a diuretic that works by decreasing sodium reabsorption in the kidneys and is classified as a sulfonamide loop diuretic commonly used for fluid overload in heart and kidney failure. Which diuretic is this?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1033, "completion_tokens": 91, "total_tokens": 1124, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b74b53c8190a0e63f0271a5608d", "custom_id": "Carvedilol-Efavirenz-Lamivudine-Metoprolol-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "c579b7dc7e0fc8ccb148b3d4701d45bd", "body": {"id": "chatcmpl-BNOT3y2Kn7wljD8fjudAyJb1xnIaz", "object": "chat.completion", "created": 1744915297, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for chronic hepatitis B and HIV with a nucleoside reverse transcriptase inhibitor that may cause gastrointestinal and respiratory symptoms begins experiencing speech difficulties. If these issues are suspected to be related to an interaction with a cardioselective \u03b21-blocker commonly prescribed for angina and hypertension, which drug is likely involved as the interacting agent causing this adverse effect?\n\nAnswer: Metoprolol", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1210, "completion_tokens": 82, "total_tokens": 1292, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b74c6fc8190a1ad000038e95253", "custom_id": "Ketoprofen-Lamivudine-Metoprolol-Fulvestrant-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "2ddfbf69e2044633c67d17578a6469f7", "body": {"id": "chatcmpl-BNOT6IvJG4o5ir7Y5aeaxFVXMCDFX", "object": "chat.completion", "created": 1744915300, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with a history of hypertension and arrhythmia is being managed on a cardioselective \u03b21-adrenergic receptor antagonist metabolized by CYP2D6 variability and known for side effects such as insomnia and presyncope. After developing advanced, hormone receptor-positive, HER2-negative breast cancer with disease progression following endocrine therapy, she is prescribed a first-in-class injectable selective estrogen receptor degrader. Clinical reports indicate that co-administration of these two drugs may result in upper abdominal pain. Based on this interaction, which drug was the new antiestrogenic agent added to her regimen?\n\nAnswer: Fulvestrant", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1002, "completion_tokens": 129, "total_tokens": 1131, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b74d8448190ad9eb74b603389fd", "custom_id": "Citalopram-Gemfibrozil-Sildenafil-Acamprosate-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "a5a4d2b8e7cbc5585e9f1826ee81a3d0", "body": {"id": "chatcmpl-BNOT91KCtl54Ho0Y6aG5uVLcRVOj3", "object": "chat.completion", "created": 1744915303, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich medication, known for alleviating cravings resulting from alcohol withdrawal by stabilizing disrupted chemical signaling in the brain, is reported to be associated with weight loss when co-administered with a selective PDE5 inhibitor commonly prescribed for erectile dysfunction and pulmonary arterial hypertension?\n\nAnswer: Acamprosate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1212, "completion_tokens": 60, "total_tokens": 1272, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b74e7808190ae1419200ef53b66", "custom_id": "Fenofibrate-Modafinil-Pamidronic acid-thiotepa-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "a8846e48a4929c2cb34ca1a0cd79b952", "body": {"id": "chatcmpl-BNOTBsQ89IsyZ2WpBPPCdCQIvQSaf", "object": "chat.completion", "created": 1744915305, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich anti-cancer medication, known as an organophosphorus compound, is associated with an increased risk of erythema when co-administered with a nitrogen-containing bisphosphonate used for osteoporosis, where that bisphosphonate itself may elevate blood pressure when combined with a centrally-acting wakefulness-promoting agent?\n\nAnswer: thiotepa", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 885, "completion_tokens": 74, "total_tokens": 959, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b74f9508190b60e6e32dafda1bc", "custom_id": "Alprazolam-Sibutramine-Zolpidem-Perindopril-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "4fc6f4acfd7d4a7886832b291dc00922", "body": {"id": "chatcmpl-BNOTCPapnAhiDzYLrk6oa7DhALcec", "object": "chat.completion", "created": 1744915306, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with sleep-onset insomnia has been prescribed a fast-acting, nonbenzodiazepine hypnotic that acts as a positive allosteric modulator of GABAA receptors and is commonly used for short-term management of sleep disorders in the United States. If this patient subsequently takes a long-acting antihypertensive prodrug that inhibits angiotensin-converting enzyme, promotes vasodilation and natriuresis, and whose formulations require hepatic activation, which agent\u2014according to known drug interactions\u2014could experience a loss of weight when combined with the hypnotic?\n\nAnswer: Perindopril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1268, "completion_tokens": 125, "total_tokens": 1393, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68014b75085c81909888da4b10372634", "custom_id": "Candesartan-Dexpramipexole-Ticlopidine-Tirofiban-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "a841afbcd6b79dd6d3ac356c99fc90f8", "body": {"id": "chatcmpl-BNOT336cMDwQNKoumkEcwgn7d1ENL", "object": "chat.completion", "created": 1744915297, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nWhich drug, when combined with an antiplatelet medication used to reduce the risk of thrombotic strokes that is associated with rare but serious side effects like neutropenia and thrombotic microangiopathy, can result in thrombocytopenia due to their interaction?\n\nAnswer: Tirofiban", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 842, "completion_tokens": 64, "total_tokens": 906, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68014b7519508190a080559ab2a555a4", "custom_id": "Candesartan-Citalopram-Dapsone-Perindopril-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "3c249a510f2d988b7eddf408ec6fde8c", "body": {"id": "chatcmpl-BNOT3MvOBqY2fjzqLx4ObqnBtz2nh", "object": "chat.completion", "created": 1744915297, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for leprosy and prophylaxis against certain infections with a sulfone-class bacteriostatic agent, which can cause side effects such as hemolytic anemia and methemoglobinemia, develops acute kidney failure after beginning a long-acting ACE inhibitor prodrug indicated for hypertension and heart failure that is converted to its active form in the liver and increases plasma renin activity. Which antihypertensive agent is most likely responsible for this adverse reaction?\n\nAnswer: Perindopril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1200, "completion_tokens": 104, "total_tokens": 1304, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68014b752d548190a9c9169ab0a7ff37", "custom_id": "Ketorolac-Oxaprozin-Sildenafil-Acamprosate-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "ad17c5d3be25b6b81e90509c81008c90", "body": {"id": "chatcmpl-BNOT6sZXYs4OJibNupvtkxePwcs0x", "object": "chat.completion", "created": 1744915300, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA selective inhibitor of phosphodiesterase type 5, when taken together with a medication that reduces cravings in alcoholism and stabilizes chemical signaling disrupted by alcohol withdrawal, may lead to which agent being associated with weight loss as a potential interaction outcome?\n\nAnswer: Acamprosate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1155, "completion_tokens": 58, "total_tokens": 1213, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b753d6881909dabc4311adfe3f9", "custom_id": "Aciclovir-Doxazosin-Metoprolol-Perphenazine-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "90ba1c7035cb73adf88c08e940e92e69", "body": {"id": "chatcmpl-BNOT7rhvJBIfuWWHtJZqX83naCoAV", "object": "chat.completion", "created": 1744915301, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with a history of angina and hypertension is being treated with a cardioselective \u03b21-adrenergic receptor antagonist known for negative chronotropic effects and metabolized via cytochrome P450 2D6. When this medication is co-administered with a medium-potency typical antipsychotic classified as a piperazinyl phenothiazine, there is a risk of precipitating insulin dependent diabetes mellitus due to their interaction. Based on this scenario, which antipsychotic is being described?\n\nAnswer: Perphenazine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 999, "completion_tokens": 114, "total_tokens": 1113, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b754db08190aafae3bc9cea0bbb", "custom_id": "Carvedilol-Metolazone-Sildenafil-Zaleplon-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "af5add43f7e9564021b22a046d26fe79", "body": {"id": "chatcmpl-BNOT3w9b4qXe7MFcW3weEcK3DjhH8", "object": "chat.completion", "created": 1744915297, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA sedative-hypnotic agent of the pyrazolopyrimidine class, approved in 1999 for the treatment of insomnia, is associated with the risk of apoplexy when used in combination with a selective phosphodiesterase type 5 inhibitor prescribed for erectile dysfunction and pulmonary arterial hypertension. Which drug fits this description?\n\nAnswer: Zaleplon", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1018, "completion_tokens": 77, "total_tokens": 1095, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68014b755dc88190bca0af5c7f2a9b21", "custom_id": "Candesartan-Citalopram-Zolpidem-Perindopril-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "d76398b7a1af54a797bbc2057577349f", "body": {"id": "chatcmpl-BNOT3Wqo1oTZWQi3dseUmMh8eOwLf", "object": "chat.completion", "created": 1744915297, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for insomnia with a nonbenzodiazepine hypnotic agent known for its GABAA receptor modulation and short half-life is considering starting a medication that acts as a long-acting prodrug ACE inhibitor, primarily used for hypertension and heart failure, which, after hepatic activation, promotes vasodilation and natriuresis. According to reported drug-drug interactions, which antihypertensive agent, when combined with the hypnotic described, is specifically associated with a side effect of weight loss?\n\nAnswer: Perindopril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1222, "completion_tokens": 112, "total_tokens": 1334, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b756e98819094cc8908e1c622b6", "custom_id": "Amphetamine-Modafinil-Pamidronic acid-thiotepa-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "aeca947a5001572393928cf49de28b25", "body": {"id": "chatcmpl-BNOT5puJMrhLp2IAh4AZnnPV5T6Lx", "object": "chat.completion", "created": 1744915299, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nGiven a nitrogen-containing bisphosphonate commonly prescribed to prevent osteoporosis that, when co-administered with an anti-cancer organophosphorus compound, can result in erythema, which anti-cancer medication is involved in this interaction?\n\nAnswer: thiotepa", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 937, "completion_tokens": 57, "total_tokens": 994, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b757eb481908f68b16a633cea69", "custom_id": "acetazolamide-Citalopram-Isoniazid-Emtricitabine-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "c4d500efe722dde6393447b45df5a7db", "body": {"id": "chatcmpl-BNOT4zH4hhruDUmRGpCgRwA5MwoGI", "object": "chat.completion", "created": 1744915298, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for tuberculosis with an antibiotic that is effective against both active and latent infections, which can be administered orally or intramuscularly, develops an enlarged liver after initiating a medication that is an essential nucleoside reverse-transcriptase inhibitor integral to both pre-exposure prophylaxis and multi-drug regimens targeting HIV infection. Which drug most likely contributed to this liver enlargement when combined with the tuberculosis therapy?\n\nAnswer: Emtricitabine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1190, "completion_tokens": 94, "total_tokens": 1284, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b758dcc8190b664ddfa1329dbc0", "custom_id": "Celecoxib-chlortalidone-Sildenafil-Acamprosate-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "70e74103fdeb103a834147b926909e0d", "body": {"id": "chatcmpl-BNOT41arWgd02ssGT4YSkWUAriUSJ", "object": "chat.completion", "created": 1744915298, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA medication used to reduce cravings in alcoholism by stabilizing brain chemical signaling, which alone is not typically effective for full treatment but helps facilitate abstinence or reduced alcohol intake, and which is associated with side effects like diarrhea and abnormal heart rhythms, is known to cause loss of weight when taken together with a drug that is primarily utilized for erectile dysfunction and pulmonary arterial hypertension via cGMP-mediated vasodilation. Which drug matches this description?\n\nAnswer: Acamprosate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1301, "completion_tokens": 96, "total_tokens": 1397, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68014b759cf88190897ff70dfa67d19b", "custom_id": "Lamotrigine-Metolazone-Pamidronic acid-thiotepa-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "b7890a195711f1163a6ed9bd6dd32c52", "body": {"id": "chatcmpl-BNOT5Ls1tf2aUcQqfmdAZzpwJEUJZ", "object": "chat.completion", "created": 1744915299, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient undergoing therapy with a nitrogen-containing bisphosphonate approved in 1987 for osteoporosis prevention develops erythema after administration of an organophosphorus anticancer compound with the formula (C2H4N)3PS. Which agent, described above, is most likely responsible for this interaction?\n\nAnswer: thiotepa", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 827, "completion_tokens": 70, "total_tokens": 897, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68014b75b2048190b3314aad9875f47d", "custom_id": "Alprazolam-Lidocaine-vincristine-Torasemide-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "96edba90965aed724566c64c1fcb8a23", "body": {"id": "chatcmpl-BNOT7sStxKpqnUq315WxD2s5WskJj", "object": "chat.completion", "created": 1744915301, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA chemotherapeutic agent derived from a plant source, which inhibits mitosis by binding tubulin and is notorious for peripheral neuropathy, when co-administered with a sulfonamide loop diuretic used primarily to manage fluid overload in heart failure, kidney, and liver diseases (but less preferred for hypertension), may increase the risk of non-specific drug toxicity as described in their interaction profile. Which drug is the loop diuretic in this context?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1271, "completion_tokens": 99, "total_tokens": 1370, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b75c87c8190bf2214afecf3aba2", "custom_id": "alendronic acid-Lamivudine-Metoprolol-Bimatoprost-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "c46c00015a1f5d4913b8d996f5946385", "body": {"id": "chatcmpl-BNOT4cWwTO6HLQrhWHpeuKGKQcDAp", "object": "chat.completion", "created": 1744915298, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with hypertension, managed using a medication that reduces heart rate and is metabolized by hepatic CYP2D6, begins experiencing exertional shortness of breath after starting an ophthalmic prostaglandin analog prescribed for inadequate response to other glaucoma therapies. Based on reported drug-drug interaction outcomes, which agent is most likely responsible for this new symptom when combined with the cardioselective \u03b21-blocker?\n\nAnswer: Bimatoprost", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1141, "completion_tokens": 91, "total_tokens": 1232, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b75da288190a811c443762fd572", "custom_id": "acetazolamide-Haloperidol-indometacin-Terazosin-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "b90caabdfea8fd151328e3b4194db566", "body": {"id": "chatcmpl-BNOT6oyuMmRMw9amSjcmvcx4EXX7M", "object": "chat.completion", "created": 1744915300, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA prescription anti-inflammatory drug that reduces pain and swelling by inhibiting prostaglandin synthesis, and that has been on the market since the early 1960s, has a documented interaction with a medication used to treat symptoms of enlarged prostate and hypertension\u2014an alpha-1 blocker taken orally\u2014resulting in a potential side effect of erythema when both are administered concurrently. Which drug serves as the alpha-1 blocker in this interaction?\n\nAnswer: Terazosin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1137, "completion_tokens": 97, "total_tokens": 1234, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b75eb388190bf3a566a2b6e4b60", "custom_id": "Doxazosin-Fluorouracil-vincristine-Torasemide-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "60ccc46bd9646fbeaaa5d16b0b10ce46", "body": {"id": "chatcmpl-BNOT9B3ujzS9a2UwSPJYCmvPfQ0lm", "object": "chat.completion", "created": 1744915303, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient undergoing chemotherapy with a vinca alkaloid that disrupts microtubule assembly (noted for causing peripheral neuropathy and neuromuscular impairment) develops heightened drug toxicity when also prescribed a sulfonamide loop diuretic used for treating fluid overload in heart failure and known to cause increased urination, headache, and the risk of low blood potassium. Which medication, fitting the latter description, is associated with this increased toxicity according to drug-drug interaction data?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1170, "completion_tokens": 105, "total_tokens": 1275, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b75ffb88190925ef7697b437644", "custom_id": "Amlodipine-Metronidazole-vincristine-Torasemide-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "51dfdf89ec0111b06bc9d64e13f50e8d", "body": {"id": "chatcmpl-BNOT7chl4jbnmIQDtWmYvrkuUL0ri", "object": "chat.completion", "created": 1744915301, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient undergoing mitotic inhibitor therapy for leukemia develops severe toxic reactions when subsequently administered a sulfonamide loop diuretic commonly used for fluid overload in heart failure and available both orally and intravenously. Which drug, when co-administered with the vinca alkaloid that disrupts microtubule assembly, is responsible for this non-specific drug toxicity?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1155, "completion_tokens": 81, "total_tokens": 1236, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b7611cc8190be8f940ba2fd81de", "custom_id": "Norfloxacin-Zolpidem-vincristine-Torasemide-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "9a61c5478ee0380f6e88826655c6d53f", "body": {"id": "chatcmpl-BNOT4wJ780MFEi3fSgMlpx3fVRGuo", "object": "chat.completion", "created": 1744915298, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for acute lymphoblastic leukemia with an intravenously administered mitotic inhibitor derived from Catharanthus roseus, known for its neurotoxic profile and risk of fatality if given intrathecally, experiences an increase in adverse drug effects after receiving an oral or intravenous loop diuretic, which is primarily prescribed for fluid overload due to heart or kidney failure and is listed on the WHO's list of essential medicines. Which medication is most likely responsible for this interaction, resulting in increased drug toxicity for the antineoplastic agent?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1185, "completion_tokens": 118, "total_tokens": 1303, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b762268819094b38db8bcf0306e", "custom_id": "Naproxen-Risedronic acid-vincristine-Torasemide-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "9c7d83454ef40311584f82189069da3f", "body": {"id": "chatcmpl-BNOT56kAo9CREcTFl0OFrGK47KB3F", "object": "chat.completion", "created": 1744915299, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient receiving intravenous therapy with a vinca alkaloid derived from Catharanthus roseus, which disrupts microtubule formation to treat certain leukemias and lymphomas but carries risks such as neuropathy and fatal consequences if administered intrathecally, begins treatment for fluid overload related to heart or kidney disease with a sulfonamide loop diuretic that increases urinary sodium excretion. Based on known drug interactions, which medication could increase the unspecified drug toxicity risk when combined with this intravenous chemotherapy?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1089, "completion_tokens": 111, "total_tokens": 1200, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68014b7632108190b4e4232e839aabba", "custom_id": "Ofloxacin-Oxaprozin-Sildenafil-Acamprosate-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "068f6973a3b179c54bba18f0cbf92840", "body": {"id": "chatcmpl-BNOT7jYqb71NaXwhPVhCSbzREHSvw", "object": "chat.completion", "created": 1744915301, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with a history of erectile dysfunction and pulmonary hypertension decides to start taking a medication that reduces cravings and stabilizes brain chemical signaling during alcohol withdrawal, but is concerned after learning that co-administration with a selective phosphodiesterase type 5 inhibitor known for vasodilatory effects may result in loss of weight. Based on drug interaction data, which medication are they considering that is associated with this outcome when used with the aforementioned vasodilator?\n\nAnswer: Acamprosate", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1055, "completion_tokens": 98, "total_tokens": 1153, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68014b7644148190a5e67aea7a7a05d5", "custom_id": "Cimetidine-Ibuprofen-Modafinil-Bimatoprost-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "ad271ff9322e2cfe7c40a00f0d9991e4", "body": {"id": "chatcmpl-BNOT9nfvfRmQ2TI94RNsLtj81xtVi", "object": "chat.completion", "created": 1744915303, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated for narcolepsy with a central nervous system stimulant that increases wakefulness may develop nocturia when this agent is taken concomitantly with an eye drop medication that is primarily prescribed to lower intraocular pressure in conditions such as open angle glaucoma, and is also sometimes used cosmetically to enhance eyelash growth. Which medication, known for causing eye redness, dryness, and possible changes in eye color, is most likely responsible for this interaction?\n\nAnswer: Bimatoprost", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1081, "completion_tokens": 100, "total_tokens": 1181, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b76572481909cc2e3a7efd84005", "custom_id": "Carvedilol-Dexpramipexole-Ticlopidine-Tirofiban-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "1246e6cbe01d83bfaa9ec27aeb10210f", "body": {"id": "chatcmpl-BNOTABYk82AN6btNedxtn0qj0mnje", "object": "chat.completion", "created": 1744915304, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient being treated to reduce the risk of thrombotic stroke with a thienopyridine-family antiplatelet (approved in 1978 and now less commonly used due to risk of neutropenia and the availability of safer alternatives) starts a second antiplatelet that acts as a small molecule inhibitor of the protein-protein interaction between fibrinogen and the GP IIb/IIIa platelet integrin receptor, derived originally from pharmacophore-based virtual screening. Based on known drug-drug interactions, which antiplatelet agent is associated with an increased risk of thrombocytopenia when added to the therapy?\n\nAnswer: Tirofiban", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 962, "completion_tokens": 137, "total_tokens": 1099, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b766b68819088e08819eecb734c", "custom_id": "alendronic acid-Alprazolam-Fluorouracil-vincristine-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "f20212d49933c156bf5c9247619749e2", "body": {"id": "chatcmpl-BNOT9JLLbL7NZvd2zOmTujJrXd7aU", "object": "chat.completion", "created": 1744915303, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nAmong the four medications described, identify the one that, when used in conjunction with a pyrimidine analog chemotherapy agent known to inhibit thymidylate synthase and indicated for colorectal and other carcinomas, has been associated with increased risk of bleeding as described in their interaction profile.\n\nAnswer: vincristine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1187, "completion_tokens": 64, "total_tokens": 1251, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68014b767ffc81909d5c6e3a40599347", "custom_id": "Famotidine-Metolazone-Dexpramipexole-Ticlopidine-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "12fc1f7a0c85b561e5dc0f622f11bb75", "body": {"id": "chatcmpl-BNOT61ezwfYt96nVFnfFOA0dtO8t9", "object": "chat.completion", "created": 1744915300, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA first-in-class oral investigational medicine that significantly reduces blood and tissue eosinophils, primarily under development for eosinophilic asthma, has been shown in clinical trials to interact with an older antiplatelet drug\u2014used to lower thrombotic stroke risk by inhibiting the ADP receptor\u2014so that patients experience hyperglycaemia as a result. Based on this interaction, which medication is associated with hyperglycaemia when taken alongside the eosinophil-lowering investigational drug?\n\nAnswer: Ticlopidine", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 961, "completion_tokens": 110, "total_tokens": 1071, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
{"id": "batch_req_68014b76929c81908d23f593da79dd88", "custom_id": "Aciclovir-Dipyridamole-Sildenafil-Zaleplon-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "c797ad4f8bcf68c1f4ef79729d62dbc4", "body": {"id": "chatcmpl-BNOTDFwnt4a0zokN1xSJDdeNYhsLR", "object": "chat.completion", "created": 1744915307, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA nonbenzodiazepine sedative-hypnotic that is a pyrazolopyrimidine and approved in the United States in 1999 is known to interact with a selective PDE5 inhibitor\u2014used for erectile dysfunction and pulmonary hypertension and notable for risks like hypotension and priapism\u2014in a manner that may precipitate apoplexy. Which drug fits this description?\n\nAnswer: Zaleplon", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 881, "completion_tokens": 86, "total_tokens": 967, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b76a32c8190a2e9069286b46248", "custom_id": "Celecoxib-Lamotrigine-Zolpidem-Bimatoprost-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "003007def2c51f4cc16f13f75ad0ad41", "body": {"id": "chatcmpl-BNOT6Mrlh97ifYOTaORLTgECEQ7ZM", "object": "chat.completion", "created": 1744915300, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nAmong the following options, which medication\u2014characterized as a prostaglandin analog administered as an eye drop for treating elevated intraocular pressure in glaucoma and for enhancing eyelash growth, with side effects including changes in eye appearance and used when other agents are insufficient\u2014has been reported to cause abnormal ECG findings specifically when combined with a nonbenzodiazepine hypnotic that acts as a positive allosteric modulator of the GABAA receptor?\n\nAnswer: Bimatoprost", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1313, "completion_tokens": 99, "total_tokens": 1412, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b76b6c48190ac693ab8cb0bf701", "custom_id": "Diazepam-Ofloxacin-Oxaprozin-Sildenafil-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "598b02228fa04719a413b072f6e51d22", "body": {"id": "chatcmpl-BNOT9puvG0FiU2oQ7FG6VIKIh6XOr", "object": "chat.completion", "created": 1744915303, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA nonsteroidal anti-inflammatory drug indicated for juvenile rheumatoid arthritis can cause gastric inflammation when taken with a selective phosphodiesterase type 5 inhibitor used for erectile dysfunction and pulmonary arterial hypertension through its enhancement of nitric oxide-mediated vasodilation. Which drug is this latter phosphodiesterase inhibitor?\n\nAnswer: Sildenafil", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1196, "completion_tokens": 66, "total_tokens": 1262, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b76ca948190b5613aa466a48292", "custom_id": "Metronidazole-Zolpidem-vincristine-Torasemide-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "f74a959ff7e89c6f47758da2e4ab333b", "body": {"id": "chatcmpl-BNOTAGl0yASPratU7Sy23giMM2cVN", "object": "chat.completion", "created": 1744915304, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA loop diuretic, patented in the 1970s and commonly prescribed for fluid overload due to cardiac, renal, or hepatic conditions, may increase the risk of unspecified drug toxicity when administered with a vinca alkaloid that disrupts microtubule assembly and is used in cancer therapy. Which medication is this diuretic?\n\nAnswer: Torasemide", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1283, "completion_tokens": 77, "total_tokens": 1360, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b76db208190a14a47abb183ca77", "custom_id": "Amlodipine-Furosemide-Lamotrigine-Oxaprozin-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "18b4cefc5215c9846d181bdd663d7a10", "body": {"id": "chatcmpl-BNOT6fqPvFDkQoMlzqziOUDkFrKho", "object": "chat.completion", "created": 1744915300, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA drug used to relieve inflammation, swelling, stiffness, and joint pain in conditions like osteoarthritis and rheumatoid arthritis is known to interact with a phenyltriazine anticonvulsant that stabilizes mood in certain bipolar disorder patients and treats epilepsy. This interaction results in an adverse effect described as \"bulging.\" Which drug is this propionic acid derivative?\n\nAnswer: Oxaprozin", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1077, "completion_tokens": 80, "total_tokens": 1157, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_7439084672"}}, "error": null}
{"id": "batch_req_68014b76eac4819097648a058131824f", "custom_id": "Carvedilol-Famotidine-Repaglinide-Perindopril-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "04592435f68203e305befddd1604c04b", "body": {"id": "chatcmpl-BNOT7p2e2qty7YGePrTojtcJfVKtF", "object": "chat.completion", "created": 1744915301, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with type 2 diabetes is effectively controlling blood glucose levels by stimulating pancreatic insulin release using a meglitinide class medication. If this patient starts treatment with a potent long-acting ACE inhibitor that is a prodrug converting in the liver to an active moiety that increases plasma renin activity and promotes natriuresis for hypertension, which additional medication is most likely associated with the onset of nasal sinus congestion due to a drug-drug interaction?\n\nAnswer: Perindopril", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1104, "completion_tokens": 99, "total_tokens": 1203, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_ac00b0000c"}}, "error": null}
{"id": "batch_req_68014b76fd3c8190ba25d72536ed7f9f", "custom_id": "Fentanyl-Labetalol-Metoprolol-Fulvestrant-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "69847de543e9932cc7352fb2eeb9c93b", "body": {"id": "chatcmpl-BNOT7WhR2iDxsDSJUsj2gEx3otNzr", "object": "chat.completion", "created": 1744915301, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA postmenopausal woman receiving a selective estrogen receptor degrader to treat hormone receptor-positive, HER2-negative advanced breast cancer is administered in combination with a cardioselective \u03b21-adrenergic receptor antagonist frequently used for hypertension and post-myocardial infarction prophylaxis. Based on their established drug-drug interaction, which medication is associated with causing upper abdominal pain when used concurrently with the \u03b21-adrenergic receptor antagonist?\n\nAnswer: Fulvestrant", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1160, "completion_tokens": 97, "total_tokens": 1257, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_c1d5f5ab92"}}, "error": null}
{"id": "batch_req_68014b770eac81909cb24d958c41811b", "custom_id": "acetazolamide-Haloperidol-Rosiglitazone-Bimatoprost-DDI-Bio-3_hop", "response": {"status_code": 200, "request_id": "1b8b4d3f2c33afb02144bb99f0212ee1", "body": {"id": "chatcmpl-BNOTDGGf4GLqVsw0VIyui58135W6p", "object": "chat.completion", "created": 1744915307, "model": "gpt-4.1-2025-04-14", "choices": [{"index": 0, "message": {"role": "assistant", "content": "Question:\nA patient with Type 2 diabetes mellitus is being treated with an agent known for enhancing insulin sensitivity by acting as a PPAR\u03b3 agonist, whose safety profile has been debated due to concerns over myocardial infarction risk. If this patient concurrently uses an ophthalmic medication indicated for high intraocular pressure, typically administered when first-line agents are insufficient and also known for increasing eyelash size and possibly causing dry or red eyes, what medication could interact with the PPAR\u03b3 agonist to increase the risk of adenopathy?\n\nAnswer: Bimatoprost", "refusal": null, "annotations": []}, "logprobs": null, "finish_reason": "stop"}], "usage": {"prompt_tokens": 1201, "completion_tokens": 112, "total_tokens": 1313, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_cf18407276"}}, "error": null}
